Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd., a foreign private issuer, for the month of November 2018. The filing, dated November 5, 2018, incorporates by reference a press release titled "Cellect Receives Multiple Patent Grants." The registrant's principal executive office is located in Kfar Saba, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on intellectual property developments rather than financial performance.
Material Changes
The material change reported is the receipt of multiple patent grants by the company. No financial changes versus the prior comparable period are disclosed in this document.
Outlook, Risks, and Management Commentary
Management commentary is limited to the announcement of the patent grants. The filing does not contain specific guidance, outlook, risk factors, contingencies, or unusual items beyond the incorporation of the press release regarding intellectual property.
Key Facts for Investor Verification
- Verify the specific patents granted and their relevance to Cellect's core technology platform.
- Confirm the jurisdiction and scope of protection for the newly granted patents.
- Review the company's most recent Form 20-F for actual financial performance data, as this 6-K contains no financial figures.